Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Anticancer Res. 2009 Oct;29(10):3819–3824.

Figure 1.

Figure 1

HET0016 inhibits proliferation of 786-O and 769-P renal adenocarcinoma cells. Equal numbers of either 786-O (A, B) or 769-P (C, D) cells were plated and next day (0 hrs) transferred to serum-free medium containing either EGF (A, C) or ET-1 (B, D). Cells were exposed either to 10 μM HET0016 (solid lane), or vehicle (dotted lane). Cell counting was performed at the day of transfer to serum free medium (0 hrs) and 24, 48 and 72 hours thereafter. Medium was changed to fresh containing mitogens and drugs every 24 hours. Data presented are characteristic experiment from at least two separate experiments, each performed in triplicate.